News Spotlight : Latest Podcast

Leading the Shift Towards Value-Based Care with Atrius Health CEO Dr. Steve Strongwater

Atrius Health is way ahead of the curve when it comes to risk-based reimbursement models. With 715 doctors providing care to approximately 745,000 patients, Atrius Health has quickly grown ...

LISTEN ON ITUNES LISTEN ON SPOTIFY

News Spotlight : Latest News

Dr. Melvin Weinstein Becomes a Member of First Light Diagnostics Clinical Advisory Board

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Melvin P. Weinstein, M.D., to the company's world-class, international Clinical Advisory Board.

READ THE FULL ARTICLE

News

LRVHealth

  • In Episode 8 of “Healthcare is Hard: A Podcast for Insiders,

    With news this week that Karen DeSalvo is joining Google as its first chief health officer, it's worth dipping into the #HealthcareIsHard archive. Karen's conversation with @Keith J. Figlioli touches on a number of key #DigitalHealth issues. Give it a listen (or download for later) here: https://lnkd.in/ebEU8tv

  • In Episode 8 of “Healthcare is Hard: A Podcast for Insiders,

    In the latest episode of Healthcare is Hard: A Podcast for Insiders, Keith J. Figlioli talks to Atrius Health CEO Steven Strongwater about how his organization is leading the shift to value-based care and now derives nearly 80% of its revenue from full-risk contracts. Listen here: https://lnkd.in/e4V5CKp

  • AI as a tool for healthcare is promising, but the relationship isn't yet fully realized. We ask: what are the main challenges to AI adoption in healthcare?

    LRVHealth's Keith J. Figlioli shared a few thoughts with Disruptor Daily about the challenges the healthcare industry will face with AI adoption:

Follow

LRVHealth and Portfolio News

November 14, 2019
Dr. Melvin Weinstein Becomes a Member of First Light Diagnostics Clinical Advisory Board

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Melvin P. Weinstein, M.D., to the company's world-class, international Clinical Advisory Board.

Read Full Article >
November 6, 2019
Dr. Jeremy Friese of Verata Health Invited to Discuss the State of Prior Authorizations with Minnesota Hospital Association and North Memorial Health Leadership

Faced with growing prior authorization burden across the state of Minnesota the Minnesota Hospital Association announced a webinar with Dr. Jeremy Friese, CEO of Verata Health, Matt Anderson, Interim CEO of Minnesota Hospital Association, and Nate Dell, VP of Revenue Cycle Management at North Memorial Health to understand the current challenges faced by Minnesota providers and potential solutions.

Read Full Article >
November 5, 2019
Censinet Joins Third Party Risk Association to Help Healthcare Providers Mitigate Risk

Censinet, the third-party risk management company for healthcare providers, today announced that it joined the Third Party Risk Association (TPRA), a non-profit professional association for third party risk practitioners and vendors. As part of this commitment, Censinet’s CEO and founder, Ed Gaudet, will present during TPRA’s 2019 Virtual Conference, “Third Party Risk Program Tools and Techniques,” which is taking place Wednesday, November 6, 2019 from 9:00am to 4:30pm CT.

Read Full Article >
November 1, 2019
First Light Diagnostics Joins Global Initiative to Combat Antibiotic Resistance

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation in the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR) Challenge. First Light’s MultiPath platform will help eliminate the unnecessary use and overuse of antibiotics that contribute to the rise of antibiotic-resistant pathogens by providing the care team with information to inform diagnosis at the onset of infection.

Read Full Article >